161 related articles for article (PubMed ID: 3925706)
1. Ovarian hyperstimulation for successful in vitro fertilization and embryo transfer.
Gronow MJ
Acta Obstet Gynecol Scand Suppl; 1985; 131():1-80. PubMed ID: 3925706
[No Abstract] [Full Text] [Related]
2. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
3. Superovulation strategy before in vitro fertilization.
Hillier SG; Afnan AM; Margara RA; Winston RM
Clin Obstet Gynaecol; 1985 Sep; 12(3):687-723. PubMed ID: 3933880
[TBL] [Abstract][Full Text] [Related]
4. Patterns of serum-luteinizing hormone surges in stimulated cycles in relation to injections of human chorionic gonadotropin.
Baukloh V; Fischer R; Naether O; Bohnet HG
Fertil Steril; 1990 Jan; 53(1):69-75. PubMed ID: 2104809
[TBL] [Abstract][Full Text] [Related]
5. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
[TBL] [Abstract][Full Text] [Related]
6. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation.
Venturoli S; Orsini LF; Paradisi R; Fabbri R; Porcu E; Magrini O; Flamigni C
Fertil Steril; 1986 Jan; 45(1):30-5. PubMed ID: 3080344
[TBL] [Abstract][Full Text] [Related]
7. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
[TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).
Kemeter P; Feichtinger W
Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476
[No Abstract] [Full Text] [Related]
9. Evaluation of diagnostic ultrasound as a parameter of follicular development in an in vitro fertilization program.
Buttery B; Trounson A; McMaster R; Wood C
Fertil Steril; 1983 Apr; 39(4):458-63. PubMed ID: 6832401
[TBL] [Abstract][Full Text] [Related]
10. Endocrinology of ovarian stimulation for in vitro fertilization.
Kerin JF; Warnes GM; Quinn P; Kirby C; Godfrey B; Cox LW
Aust N Z J Obstet Gynaecol; 1984 May; 24(2):121-4. PubMed ID: 6437386
[TBL] [Abstract][Full Text] [Related]
11. A study of factors affecting the success of human fertilization in vitro. I. Influence of ovarian stimulation upon the number and condition of oocytes collected.
Testart J; Frydman R; De Mouzon J; Lassalle B; Belaisch JC
Biol Reprod; 1983 Mar; 28(2):415-24. PubMed ID: 6220748
[No Abstract] [Full Text] [Related]
12. Ovarian stimulation regimens in an in vitro fertilization program: a comparative analysis.
Bayly CM; McBain JC; Clarke GA; Gronow MJ; Johnston WI; Martin MJ; Speirs AL
Ann N Y Acad Sci; 1985; 442():123-7. PubMed ID: 3925832
[No Abstract] [Full Text] [Related]
13. Luteal function following ovarian stimulation in rhesus monkeys for in vitro fertilization: atypical response to human chorionic gonadotropin treatment simulating early pregnancy.
VandeVoort CA; Hess DL; Stouffer RL
Fertil Steril; 1988 Jun; 49(6):1071-5. PubMed ID: 3131158
[TBL] [Abstract][Full Text] [Related]
14. Hormonal serum profiles and follicular development after intramuscular and pulsatile intravenous administration of human menopausal gonadotrophin.
Duijkers IJ; Hollanders HM; Willemsen WN; Thomas CM; Borm GF; Vemer HM
Eur J Endocrinol; 1995 Jul; 133(1):57-64. PubMed ID: 7627338
[TBL] [Abstract][Full Text] [Related]
15. Relationships between the characteristics of endogenous luteinizing hormone surge and the degree of ovarian hyperstimulation during superovulation induction in women.
Messinis IE; Templeton A; Baird DT
Clin Endocrinol (Oxf); 1986 Oct; 25(4):393-400. PubMed ID: 3113775
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.
San Roman GA; Surrey ES; Judd HL; Kerin JF
Fertil Steril; 1992 Oct; 58(4):744-9. PubMed ID: 1426320
[TBL] [Abstract][Full Text] [Related]
17. Timing of progesterone rise around a surge in endogenous luteinizing hormone or the injection of human chorionic gonadotropin in controlled ovarian stimulation for in vitro fertilization.
Harada T; Sekijima A; Iwabe T; Onohara Y; Tanikawa M; Terado H; Toda T; Mio Y; Terakawa N
J In Vitro Fert Embryo Transf; 1991 Feb; 8(1):56-9. PubMed ID: 1901899
[No Abstract] [Full Text] [Related]
18. The luteal phase after hyperstimulation for in vitro fertilization.
Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB
Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279
[TBL] [Abstract][Full Text] [Related]
19. Ovarian function for multiple follicle maturation.
Hodgen GD
Clin Obstet Gynecol; 1986 Mar; 29(1):127-40. PubMed ID: 3082550
[No Abstract] [Full Text] [Related]
20. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
